These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16212)

  • 21. [Pancreatic extract therapy in exocrine pancreatic insufficiency].
    Santini B; Ivaldi AP
    Minerva Gastroenterol Dietol; 1993 Sep; 39(3):133-7. PubMed ID: 8286485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An enteric-coated pancreatic enzyme preparation that works.
    Graham DY
    Dig Dis Sci; 1979 Dec; 24(12):906-9. PubMed ID: 510089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic extracts in the treatment of pancreatic exocrine insufficiency.
    Saunders JH; Wormsley KG
    Gut; 1975 Feb; 16(2):157-62. PubMed ID: 236213
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro study of a new pancreatic enzyme with high lipase content in enteric coated microtablets].
    Vantini I; Fioretta A; Bonfante F; Brentegnani MT; Benini L; Castellani G
    Clin Ter; 1993 May; 142(5):445-51. PubMed ID: 8339528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency.
    Thomson M; Clague A; Cleghorn GJ; Shepherd RW
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):407-13. PubMed ID: 8145097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic steatorrhea in children due to a congenital insufficiency of pancreatic lipase].
    Verger P; Babin R; Guillard JM; Babin JP; Cixous P; Laigle JL
    Arch Fr Pediatr; 1971 Nov; 28(9):992. PubMed ID: 5144703
    [No Abstract]   [Full Text] [Related]  

  • 28. Pancrease gastroresistance: in vitro evaluation of pH-determined dissolution.
    Lenaerts C; Beraud N; Castaigne JP
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S18-21. PubMed ID: 3404358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function.
    Braga M; Cristallo M; De Franchis R; Mangiagalli A; Agape D; Primignani M; Di Carlo V
    Surg Gynecol Obstet; 1988 Dec; 167(6):485-92. PubMed ID: 3187872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of exocrine pancreatic insufficiency with fungal lipase (author's transl)].
    Pointner H; Flegel U
    Arzneimittelforschung; 1975 Nov; 25(11):1833-5. PubMed ID: 1053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ins and outs of oral pancreatic enzymes.
    Meyer JH
    N Engl J Med; 1977 Jun; 296(23):1347-8. PubMed ID: 859534
    [No Abstract]   [Full Text] [Related]  

  • 32. Pancreatic extracts.
    Br Med J; 1970 Apr; 2(5702):161-3. PubMed ID: 5440600
    [No Abstract]   [Full Text] [Related]  

  • 33. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
    Kalnins D; Ellis L; Corey M; Pencharz PB; Stewart C; Tullis E; Durie PR
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study.
    Domínguez-Muñoz JE; Iglesias-García J; Iglesias-Rey M; Figueiras A; Vilariño-Insua M
    Aliment Pharmacol Ther; 2005 Apr; 21(8):993-1000. PubMed ID: 15813835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In-vitro analysis of substances used in pancreozymin substitution therapy].
    Malis F; Fric P
    Arzneimittelforschung; 1974 Apr; 24(4):499-504. PubMed ID: 4408063
    [No Abstract]   [Full Text] [Related]  

  • 37. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
    Löser C; Fölsch UR
    Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total pancreatic insufficiency in pigs: a model to study intestinal enzymes and plasma levels of digestive hormones after pancreatic supplementation by a whole pancreas preparation.
    Abello J; Pascaud X; Simoes-Nunes C; Cuber JC; Junien JL; Rozé C
    Pancreas; 1989; 4(5):556-64. PubMed ID: 2478998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controversies in the treatment of exocrine pancreatic insufficiency.
    DiMagno EP
    Dig Dis Sci; 1982 Jun; 27(6):481-4. PubMed ID: 6919479
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.